Industry Insights
Healthcare AI Has Crossed the Line From Experiment to Infrastructure
November 5, 2026
Executive Summary: Healthcare AI has moved from pilot programs to embedded clinical infrastructure, with roughly 40% of U.S. physicians now using OpenEvidence, according to reported metrics. That raises lab expectations for faster, more automated, AI-ready workflows. Modern laboratory information system (LIS) software platforms must evolve from passive systems of record into intelligent systems of action to keep pace.
Healthcare AI adoption is no longer theoretical. It's operational.
For years, artificial intelligence in healthcare lived in pilot programs, conference keynotes, and white papers promising future transformation. That phase is ending. What we are witnessing now is something fundamentally different: AI moving from optional innovation to embedded infrastructure inside everyday pathology and clinical lab workflow.
Few examples illustrate this shift more clearly than OpenEvidence.
Often described as "ChatGPT for clinicians," OpenEvidence earlier this year announced a $250 million Series D funding round at a $12 billion valuation, doubling its valuation in just two months. That headline is impressive, but the valuation is not the real story.
Adoption is.
According to reported metrics, OpenEvidence is now used by approximately 40% of U.S. physicians, supporting more than 18 million physician consultations per month, up from roughly 3 million a year ago. In 2025 alone, a clinician using the platform treated over 100 million Americans, with annualized revenue approaching $150 million and gross margins exceeding 90%.
Healthcare has never moved this fast.
When nearly half of practicing physicians adopt a new workflow in fewer than three years, it signals that AI has moved beyond early adoption and into standard clinical practice. Once that shift takes hold upstream, expectations inevitably change downstream, including across laboratory operations.
Discover More: LigoLab and Docus Partner to Bring AI-Driven Lab Result Interpretations to Hundreds of U.S. Labs
Why Does Physician AI Adoption Matter to Laboratories?
At first glance, OpenEvidence may seem like a physician-facing tool with limited relevance to laboratories. That would be a mistake.
Physicians are rapidly normalizing AI as part of daily clinical decision-making, not as a novelty or an experiment, but as infrastructure. Once clinicians internalize that AI can deliver fast, reliable, evidence-based answers at the point of care, they begin to expect the same intelligence, speed, and automation from all laboratory software systems they use.
That expectation inevitably flows to diagnostic services.
For clinical laboratories, reference labs, and pathology practices, this shift has profound implications:
- Faster answers become non-negotiable.
- Manual review and data latency become unacceptable.
- Fragmented systems become visible liabilities.
- Legacy LIS systems alone are no longer sufficient.
In an AI-native medical environment, laboratories are no longer judged solely on analytical accuracy. They are judged on how effectively they integrate into intelligent, automated workflows.
Industry Insights: The Future of Laboratory Diagnostics - Emerging Technologies and Patient-Centric Care
What Does OpenEvidence's Growth Model Signal About Where Healthcare Is Headed?
OpenEvidence's growth is not accidental. It reflects a deliberate, bottom-up adoption strategy that resonates with how modern healthcare professionals work.
Instead of selling to hospital IT departments through long procurement cycles, OpenEvidence built a doctor-first platform. Clinicians sign up directly. The platform is free. There is no enterprise gatekeeping. No implementation delays. No workflow disruption.
As the company's CEO, Daniel Nadler, emphasized in MedCity News (linked below), OpenEvidence is designed for doctors, not hospital CIOs. It meets clinicians where they are: during rounds, between shifts, late at night reviewing cases, and provides answers sourced from trusted, peer-reviewed medical literature, including JAMA, the American Medical Association, and the New England Journal of Medicine.
That trust matters.
Physicians are savvy consumers of technology. They know when a system is built to serve them. OpenEvidence's daily engagement, on average, one or more questions per clinician per day, reflects that trust and relevance.
Get Insight: Thunderstruck By OpenEvidence’s $12B Valuation? Don’t Be

How Will AI Expectations Reshape Laboratory Information Systems?
As physicians grow accustomed to AI-assisted reasoning, laboratories must ask a critical question: Are our diagnostic lab software systems ready to operate at the same speed and level as AI-driven medical workflows?
In many environments, the answer today is no.
The legacy laboratory information system (LIS) was designed as a system of record, a place to store results, manage accessioning, and support compliance. That foundation remains important, but it is no longer sufficient.
LIS System of Record vs. System of Action at a Glance

When a physician consults OpenEvidence and immediately refines a diagnostic plan, they expect laboratory workflows to keep pace, not slow them down.
Industry Insights: From System of Record to LIS System of Action - The Next Evolution of Laboratory Information Systems
How Can Clinical Labs, Reference Labs, and Pathology Groups Use AI Alongside Tools Like OpenEvidence?
While OpenEvidence isn’t a laboratory information system, its presence in clinical and pathology workflows creates clear opportunities for integration and operational alignment.
Can AI Improve Test Selection and Utilization Guidance?
Physicians often consult OpenEvidence when determining which tests are appropriate for a given clinical scenario. This creates an opportunity for laboratories to:
- Align LIS software decision rules with emerging evidence.
- Reduce unnecessary or duplicative testing.
- Support evidence-based utilization management.
- Improve test appropriateness at the order-entry stage.
Clinical laboratories that integrate AI-informed utilization logic into accessioning workflows will reduce downstream rework, improve turnaround times, and enhance clinician satisfaction.
Can AI Reduce Back-and-Forth With Clinicians?
Medical lab technicians and client services teams spend significant time answering questions about test interpretation, reflex testing, and the context of the test result.
As clinicians become accustomed to AI-assisted answers, laboratories can mirror this experience by embedding AI-driven knowledge layers directly into diagnostic lab software, reducing phone calls, emails, and manual clarifications.
Industry Insights: Business Success Through Advanced Laboratory Information System Technology - Connecting All The Pieces
How Will AI Change Pathology Practices and Anatomic Pathology Software?
Pathology stands to benefit even more directly from this AI-driven shift.
Pathologists already operate in a cognitively dense environment, synthesizing medical history, imaging, histology, and molecular data. Tools like OpenEvidence normalize the idea that AI can augment, not replace, expert judgment.
For pathology practices, this signals a future where anatomic pathology software must support:
- AI-assisted case triage and prioritization.
- Intelligent workload balancing.
- Context-aware clinical history aggregation.
- Automated quality and concordance checks.
- Faster, more consistent reporting workflows.
As pathologists increasingly rely on AI-supported clinical insights upstream, laboratory information systems and other pathology lab management platforms must deliver the same level of intelligence internally.
On-Demand Webinar: ECPC’s Strategic Leap into Digital Pathology
What Is the Role of Medical Lab Technicians in an AI-Enabled Lab?
AI adoption does not eliminate the need for skilled professionals; it elevates them.
Medical lab technicians will increasingly work alongside AI-driven tools that:
- Flag anomalies earlier.
- Reduce manual verification steps.
- Surface potential quality issues proactively.
- Automate repetitive administrative tasks.
This allows technicians to focus on higher-value work: exception handling, quality oversight, and process optimization.
Laboratories that embrace AI-assisted diagnostic lab software will improve efficiency and workforce satisfaction and retention, critical advantages in an environment of persistent staffing shortages.
Discover More: Best Practices for Preparing Medical Labs for AI Integration in Technical and Financial Operations

How Does AI Impact Laboratory Revenue Cycle Management and Lab Billing?
One of the most overlooked aspects of healthcare AI adoption is its impact on laboratory billing and reimbursement.
As OpenEvidence normalizes AI-assisted clinical reasoning, documentation becomes more precise, structured, and evidence-based. Laboratories that integrate AI into LIS software and laboratory revenue cycle management (RCM) workflows can:
- Improve medical necessity documentation.
- Reduce denials.
- Accelerate clean claims.
- Align test ordering with payer expectations.
AI-aware pathology and clinical laboratory management is more than an operational advantage; it is a financial one.
Industry Insights: Navigating the Coding Minefield - Labs Struggle with RCM Rejections Amid Rising Scrutiny from Payers
Where AI Creates Impact Across Lab Roles

Is Every Lab Ready to Adopt AI Right Now?
To be clear, physician adoption of a particular AI tool does not necessarily create the same expectations for every laboratory. Smaller labs serving a limited, established client base may face less immediate pressure to adopt AI, and the pace at which AI becomes a standard expectation will vary by client base, specialty, and geographic region.
It's also worth stating plainly that AI layered on top of fragmented or inconsistent data tends to amplify existing problems rather than solve them. Labs that haven't yet unified their technical and financial workflows, cleaned up their data, or established reliable interoperability are usually better served by fixing that foundation first. Also, because AI-driven decision support in a lab setting touches regulated workflows, it needs to be auditable, explainable, and validated, which argues for a phased, measured rollout rather than a rush to adopt every new capability at once.
Finally, "AI-enabled" is a label vendors apply loosely. Labs evaluating any platform should ask for concrete, measurable outcomes, such as turnaround time, error rates, labor efficiency, or denial reduction, rather than relying on the label alone. For labs where AI isn't yet a near-term priority, strong core automation and a unified LIS-plus-RCM foundation capture most practical benefits today and keep the door open for AI later.
From Early Adoption to Table Stakes: What Comes Next?
Healthcare adoption has historically been slow. This is not slow.
When 40% of physicians adopt a new workflow in under three years, the message is clear: AI is becoming embedded infrastructure.
For laboratories, the question is no longer whether AI becomes table stakes. The real question is how quickly you operationalize it before your customers expect it by default.
How Does LigoLab Embed Intelligence Across the Entire Lab Operations Lifecycle?
Artificial intelligence is rapidly reshaping healthcare, but pathology and clinical laboratories don't need more disconnected AI point solutions layered onto already complex workflows. They need intelligence built directly into the systems that run the lab.
That's where LigoLab is different.
LigoLab isn't building AI on top of pathology and clinical workflows. We're building a lab information system that orchestrates intelligence across them.
As laboratories move toward AI-driven operations, the all-in-one LigoLab Informatics Platform is designed to serve as a true LIS system of action, aligning clinical, operational, and financial data in a single source of truth. This foundation lets you apply intelligence consistently across the entire lab lifecycle, from order intake and accessioning to case management, lab billing, analytics, and reporting.
What Does "AI-Enabled" Mean at LigoLab?
At LigoLab, intelligence is not a bolt-on feature or experimental add-on. Every AI-driven capability is:
- Workflow-native, not layered on after the fact.
- Auditable, explainable, and compliant by design.
- Built to augment human expertise, not replace it.
- Optimized across departments, not isolated in silos.
Instead of introducing more tools to manage, LigoLab embeds intelligence directly into the workflows lab teams already use, supporting pathologists, technologists, administrators, and lab billing teams in real time.
What Measurable Outcomes Must LigoLab's AI Deliver?
Every AI capability introduced into the LigoLab platform must deliver tangible operational or financial impact. If it doesn't move a measurable needle, it doesn't ship.
Specifically, intelligence must improve at least one of the following:
- Faster turnaround times.
- Higher accuracy and fewer errors.
- Greater labor efficiency.
- Stronger revenue integrity.
- Increased clinical confidence.
By combining rule-driven automation, intelligent workflow orchestration, and AI-ready data architectures, LigoLab enables laboratories to adopt emerging AI tools with confidence, without disrupting operations or fragmenting data.
Continue Your Research
- AI Integration Guide: Best Practices for Preparing Medical Labs for AI Integration in Technical and Financial Operations
- System of Action: From System of Record to LIS System of Action - The Next Evolution of Laboratory Information Systems
- Partnership Announcement: LigoLab and Docus Partner to Bring AI-Driven Lab Result Interpretations to Hundreds of U.S. Labs
- Digital Pathology Webinar: ECPC’s Strategic Leap into Digital Pathology
Ready to Future-Proof Your Laboratory for AI-Driven Operations?
Contact LigoLab to learn how an all-in-one, AI-ready LIS system and lab billing platform can help future-proof your laboratory.
Act Now: Speak with a LigoLab Product Specialist!
Frequently Asked Questions About Healthcare AI and Laboratory Operations
What is OpenEvidence, and why does it matter to laboratories?
OpenEvidence is a clinician-facing AI platform, often described as "ChatGPT for clinicians," that provides answers sourced from peer-reviewed medical literature. It matters to labs because widespread physician use raises expectations for speed, intelligence, and automation across every system clinicians interact with, including diagnostic services.
Why does physician AI adoption affect laboratory operations?
Once clinicians get used to fast, evidence-based AI answers at the point of care, they expect the same from laboratory workflows. Manual review, data latency, and fragmented systems become visible liabilities, and labs are judged not just on analytical accuracy but on how well they integrate into intelligent, automated clinical workflows.
What is the difference between an LIS system of record and a system of action?
A system of record stores results, manages accessioning, and supports compliance. A system of action goes further, supporting real-time decision support, intelligent routing and prioritization, automated quality assurance, AI-assisted utilization management, and closed-loop billing and documentation workflows.
How can AI improve lab billing and revenue cycle management?
AI-informed documentation can strengthen medical-necessity support, reduce denials, accelerate clean claims, and align test ordering with payer expectations when integrated into LIS software and lab revenue cycle management workflows.
Will AI replace medical lab technicians or pathologists?
No. AI is positioned to augment expert judgment, not replace it. Technicians gain tools that flag anomalies earlier and reduce manual verification, freeing them to handle exceptions. In contrast, pathologists gain support for triage, workload balancing, and concordance checks.
Is every lab ready to adopt AI right now?
Not necessarily. AI layered onto fragmented or inconsistent data tends to amplify existing problems, and AI-driven decision support in regulated lab workflows should be auditable, explainable, and validated. Labs without a unified data foundation are often better served by fixing that first and adopting AI in a phased, measured way.






